PeLeMed is Drug Discovery in South Korea that focus on intractable carcinoma business. Founded in 2019. They cover business area such as developer, anti-cancer drug, patient, incurable cancer, intractable carcinoma, discovery, development, class, doctor, treatment, neurological or immune disease.
2019
( 5 years old in 2024 )
Intractable Carcinoma
-
Second floor, 643, Seolleung-ro, Gangnam-gu
Seoul, 02455
South Korea
Private
developeranti-cancer drugpatientincurable cancerintractable carcinomadiscoverydevelopmentclassdoctortreatmentneurological or immune disease
* We use standard office opening hours in near PeLeMed's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PeLeMed is Drug Discovery business from South Korea that founded in 2019 (5 years old in 2024), PeLeMed business is focusing on Intractable Carcinoma.
PeLeMed headquarter office and corporate office address is located in Second floor, 643, Seolleung-ro, Gangnam-gu Seoul, 02455 South Korea.
PeLeMed was founded in South Korea.
In 2024, PeLeMed is currently focus on intractable carcinoma sector.
Above is snippet of Google Trends for "intractable carcinoma" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PeLeMed, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
